Literature DB >> 28536861

Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.

Kathryn N Devlin1, Tania Giovannetti2.   

Abstract

Despite longstanding acknowledgement of the heterogeneity of HIV-associated neurocognitive disorders (HAND), existing HAND diagnostic methods classify according to the degree of impairment, without regard to the pattern of neuropsychological strengths and weaknesses. Research in mild cognitive impairment (MCI) has demonstrated that classifying individuals into subtypes by both their level and pattern of impairment, using either conventional or statistical methods, has etiologic and prognostic utility. Methods for characterizing the heterogeneity of MCI provide a framework that can be applied to other disorders and may be useful in clarifying some of the current challenges in the study of HAND. A small number of studies have applied these methods to examine the heterogeneity of neurocognitive function among individuals with HIV. Most have supported the existence of multiple subtypes of neurocognitive impairment, with some evidence for distinct clinicodemographic features of these subtypes, but a number of gaps exist. Following a review of diagnostic methods and challenges in the study of HAND, we summarize the literature regarding conventional and empirical subtypes of MCI and HAND and identify directions for future research regarding neurocognitive heterogeneity in HIV infection.

Entities:  

Keywords:  Cluster analysis; HIV-associated neurocognitive disorders; Latent class analysis; Mild cognitive impairment; Neurocognitive subtypes; Person-centered analyses

Mesh:

Year:  2017        PMID: 28536861     DOI: 10.1007/s11065-017-9348-2

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  157 in total

Review 1.  A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

Authors:  Daniel M Forton; Joanna M Allsop; I Jane Cox; Gavin Hamilton; Keith Wesnes; Howard C Thomas; Simon D Taylor-Robinson
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

2.  The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scales.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Danielle J Harvey; Amanda Simmons; Bruce R Reed; Charles Decarli
Journal:  Alzheimers Dement       Date:  2011-11       Impact factor: 21.566

3.  Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.

Authors:  Erin E Morgan; Steven Paul Woods; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-02-15       Impact factor: 2.813

4.  Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

Authors:  G Peavy; D Jacobs; D P Salmon; N Butters; D C Delis; M Taylor; P Massman; J C Stout; W C Heindel; D Kirson
Journal:  J Clin Exp Neuropsychol       Date:  1994-08       Impact factor: 2.475

5.  Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Authors:  Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

6.  Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project.

Authors:  E Mariani; R Monastero; S Ercolani; F Mangialasche; M Caputo; F T Feliziani; D F Vitale; U Senin; P Mecocci
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-01       Impact factor: 2.959

7.  Prevalence and persistence of mild cognitive impairment among elderly patients in general hospitals.

Authors:  H Bickel; E Mosch; E Seigerschmidt; M Siemen; H Forstl
Journal:  Dement Geriatr Cogn Disord       Date:  2006-02-07       Impact factor: 2.959

8.  HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

Authors:  J Allen McCutchan; Julia W Wu; Kevin Robertson; Susan L Koletar; Ronald J Ellis; Susan Cohn; Michael Taylor; Steven Woods; Robert Heaton; Judith Currier; Paige L Williams
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

9.  Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping.

Authors:  Bernadette McGuinness; Suzanne L Barrett; John McIlvenna; Anthony Peter Passmore; Gillian W Shorter
Journal:  Alzheimers Dement (Amst)       Date:  2015-11-02

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  9 in total

1.  Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Authors:  Daniela Gomez; Christopher Power; M John Gill; Noshin Koenig; Roberto Vega; Esther Fujiwara
Journal:  J Neurovirol       Date:  2018-12-05       Impact factor: 2.643

2.  Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders.

Authors:  Elena Cecilia Rosca; Loai Albarqouni; Mihaela Simu
Journal:  Neuropsychol Rev       Date:  2019-08-22       Impact factor: 7.444

3.  Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods.

Authors:  Kathryn N Devlin; Laura Brennan; Laura Saad; Tania Giovannetti; Roy H Hamilton; David A Wolk; Sharon X Xie; Dawn Mechanic-Hamilton
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

4.  Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women.

Authors:  Jacqueline Samantha Womersley; Georgina Spies; Gerard Tromp; Soraya Seedat; Sian Megan Joanna Hemmings
Journal:  J Neurovirol       Date:  2021-08-26       Impact factor: 3.739

Review 5.  Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis.

Authors:  Tory P Johnson; Avindra Nath
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

6.  Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts.

Authors:  Pamela E May; Abigail J Heithoff; Christopher S Wichman; Vaishali S Phatak; David J Moore; Robert K Heaton; Howard S Fox
Journal:  J Acquir Immune Defic Syndr       Date:  2020-03-01       Impact factor: 3.771

7.  Unraveling Individual Differences In The HIV-1 Transgenic Rat: Therapeutic Efficacy Of Methylphenidate.

Authors:  Kristen A McLaurin; Hailong Li; Rosemarie M Booze; Amanda J Fairchild; Charles F Mactutus
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

8.  Identifying subtypes of HIV/AIDS-related symptoms in China using latent profile analysis and symptom networks.

Authors:  Zhongfang Yang; Zheng Zhu; Huan Wen; Shuyu Han; Lin Zhang; Yanfen Fu; Yan Hu; Bei Wu
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

9.  Binge Drinking Relates to Worse Neurocognitive Functioning Among Adults Aging with HIV.

Authors:  Emily W Paolillo; Rowan Saloner; Maulika Kohli; C Wei-Ming Watson; Raeanne C Moore; Robert K Heaton; David J Moore
Journal:  J Int Neuropsychol Soc       Date:  2021-07-26       Impact factor: 3.114

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.